S 1196

  • New York Senate Bill
  • 2023 Regular Session
  • Introduced in Senate
  • Passed Senate Jun 05, 2023
  • Passed Assembly Jun 08, 2023
  • Signed by Governor Dec 22, 2023

Requires health insurance policies and medicaid to cover biomarker testing for certain purposes

Abstract

Requires health insurance policies and medicaid to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing monitoring of a covered person's disease or condition when the test is supported by medical and scientific evidence.

Bill Sponsors (34)

Votes


Actions


Dec 22, 2023

Senate

APPROVAL MEMO.76

Senate

SIGNED CHAP.754

Dec 12, 2023

Senate

DELIVERED TO GOVERNOR

Jun 08, 2023

Assembly

PASSED ASSEMBLY

Assembly

ORDERED TO THIRD READING RULES CAL.679

Assembly

RETURNED TO SENATE

Assembly

SUBSTITUTED FOR A1673A

Jun 05, 2023

Assembly

REFERRED TO WAYS AND MEANS

Senate

COMMITTEE DISCHARGED AND COMMITTED TO RULES

Senate

ORDERED TO THIRD READING CAL.1451

Senate

PASSED SENATE

Senate

DELIVERED TO ASSEMBLY

Jun 01, 2023

Senate

PRINT NUMBER 1196A

Senate

AMEND AND RECOMMIT TO FINANCE

May 22, 2023

Senate

REPORTED AND COMMITTED TO FINANCE

Jan 10, 2023

Senate

REFERRED TO INSURANCE

Bill Text

Bill Text Versions Format
S1196 PDF HTML
S1196A PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.